BRIP1 and breast cancer: To examine the effect of BRIP1 inhibition on BC cell proliferation, cells were treated with either BRIP1‐siRNA or si‐Ctrl, and cellular proliferation was assessed at 24, 48, and 72 hours post‐treatment using Alamar blue assay.